Next-generation medical devices for neurovascular disease
Finalist in the MedTech Innovator Competition
Oxford Endovascular profiles its Origami Engineering research to treat Brain Aneurysms as a finalist in the MedTech Innovator competition
Oxford Endovascular Ltd is a spin-out from Oxford University, working to prevent brain haemorrhage by curing brain aneurysms, a condition that affects 1 in 50 persons.
OxiFlow™️ is a novel, next generation flow-diverter, that diverts blood flow away from intracranial aneurysms at risk of rupture. It places more accurately and safely than existing devices, reducing the risk of complications. It conforms better to blood vessels making more patients treatable
Invented by a world-renowned physician who pioneered the treatment of aneurysms over the last 30 years and an expert in ‘origami engineering’, it has patents in Europe, US, China & Japan.
The company has raised over $10m to support its development including winning a prestigious Horizon 2020 grant from the European Union following extensive due diligence by medical, industry and investor experts.
Targeting a market over $1 billion, that is growing rapidly, Oxford Endovascular is poised for significant increased value as it addresses unmet clinical needs.
Team of Success
CEO – Mike Karim
Over 30 years of international experience in medical devices including endovascular products. Leadership roles in general management, sales & marketing and mentoring. Success in fund raising, driving business growth in large corporations, SMEs and start ups, developing and bringing new products to market.
Chairman – Chas Taylor
Experienced serial entrepreneur who has founded, led and successfully sold three MedTech companies (Veryan, Novate, MedNova), raising in excess of £100m funding from private, Venture Capital, Venture Debt and Corporate sources. Has mentored multiple businesses delivering value creation through development, regulatory and commercial strategies.
Non-exec Director – Brian Howlett
Long career as a medtech business leader including with endovascular products. Board member of three emerging medtech companies, CEO of Lombard Medical Technologies (2005-2009), General Manager of Boston Scientific in UK (1999-2005)
Clinical Director – James Byrne
Professor of Neuroradiology & Consultant Neuroradiologist with over 30 years of clinical experience treating aneurysm patients. Led over 30 courses training MDs to treat aneurysms and has a track record in prototype development and device testing.
Technology Director – Zhong You
Professor of Engineering Science and an expert in origami structures & minimally invasive medical devices. Gained funding from the Wellcome Trust Centre of Excellence to develop prototype medical devices.
News & Events